MRI-based ID of the Vasculature across the Heart-Brain Axis
Microvascular impairment is a hallmark of many of today’s most burdening diseases, including forms of ischemic heart disease, stroke, and dementia. It is also the most promising candidate to explain the link between cardiovascular...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
TIN2011-25476
ANALISIS AUTOMATICO DE IMAGENES DE RETINA Y CAROTIDA: CORREL...
92K€
Cerrado
ANATOMY-FOUND
Novel Imaging of the heart for new structural and metabolic...
200K€
Cerrado
SAF2008-00678
MEDIDA DE PERFUSION CEREBRAL EN PATOLOGIA USANDO LA TECNICA...
85K€
Cerrado
HEARTOFSTROKE
The heart of stroke Pipes Perfusion Parenchyma
1M€
Cerrado
FIS2010-19860
DIAGNOSTICO DE ANEURISMAS DE AORTA MEDIANTE NUEVAS TECNICAS...
85K€
Cerrado
CTQ2010-20960-C02-02
IMAGEN DE RESONANCIA MAGNEICA DE LA ANISOTROPIA DE LA PERFUS...
93K€
Cerrado
Información proyecto VascularID
Duración del proyecto: 66 meses
Fecha Inicio: 2023-01-31
Fecha Fin: 2028-07-31
Descripción del proyecto
Microvascular impairment is a hallmark of many of today’s most burdening diseases, including forms of ischemic heart disease, stroke, and dementia. It is also the most promising candidate to explain the link between cardiovascular and brain disease (so-called heart-brain axis). However, only histology provides comprehensive assessment of the microvasculature, and is rarely available in vivo as it requires invasive biopsy. The lack of early, non-invasive markers limits our pathophysiological understanding and crucially affects treatment success, as preventive intervention is the only successful clinical management strategy available.
With a major leap in Magnetic Resonance Imaging (MRI) physics, I will address this need and develop VascularID, a fully non-invasive toolset for the quantitative assessment of cardiac and cerebral microvasculature. This non-invasive biopsy exploits microscopic magnetic fields around the vessels to obtain structural information about the microvasculature. It is contrast-free and resilient against field inhomogeneities and can, for the first time, be used in both the heart and the brain. Combined with a new generation of non-contrast perfusion MRI, VascularID will provide comprehensive functional and structural information.
My approach will first be validated in a micro-printed 3D model of the vasculature. In vivo feasibility will be demonstrated in an animal model. Proof-of-principle studies with VascularID in a cohort of patients suffering from heart disease and a cohort of patients with cerebral small vessel disease will demonstrate the clinical feasibility.
I will develop, validate, and disseminate VascularID for research and clinical use to enable groundbreaking insights into the smallest blood vessels. These insights are perfectly poised to provide the missing key to the vascular underpinnings of diseases that form the major burden to our health care system in the years to come.